chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Cardiac enzymes normal, Catheterisation cardiac normal, Chest pain, Echocardiogram normal, Electrocardiogram ST segment elevation
Clinical narrative: This study case was received from the investigator in a trial on 22 February 2012 with additional information received on 28 February 2012. A 29-year-old male subject had received the following vaccinations: On 04 November 2009, an injection of ACAM2000 (lot number not reported). On 03 November 2009, an injection of ANTHRAX (manufacturer and lot number not reported), INFLUENZA, LIVE, INTRANASAL (manufacturer and lot number not reported) and TYPHIM VI, sanofi pasteur SA (lot number not reported). The subject had an abnormal troponin I on 13 November 2009, a normal echocardiogram on 14 November 2009 and an abnormal ECG on 15 November 2009. The subject was diagnosed with chest pain, unspecified on 13 November 2009. The subject had no significant medical history. No further information was available at the time of the report. The subject's outcome was not reported. Note: there is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received from the investigator on 19 March 2012. Fifteen days post-vaccination, the subject presented to a clinic status post (s/p) four day hospitalization for chest pain (CP) with respiration 3/10, two weeks s/p smallpox vaccine (SPV). Inpatient testing included an ECG that revealed diffuse small ST segment elevations. Cardiac catheterization and enzymes rules out myocardial infarction (MI) and atherosclerotic disease. The subject was asymptomatic and had no prior history of related symptoms. Lungs were clear to auscultation (CTA). Fifteen days post-vaccination, the subject's ECG revealed normal sinus rhythm (NSR), regular rate and rhythm (RRR) and no murmur. "A/P 1) Pericarditis: possibly related to SPV. Resolved." The subject's past medical history (PMH) included testicular cancer, orchidectomy and reflux disease. The subject's family history included cancer on the maternal side. The subject's concomitant medication was "omneprozol." The subject's outcome was recovered. Documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pericarditis, Troponin I
Clinical narrative: This study case was received from the investigator in a trial on 22 February 2012 with additional information received on 28 February 2012. A 29-year-old male subject had received the following vaccinations: On 04 November 2009, an injection of ACAM2000 (lot number not reported). On 03 November 2009, an injection of ANTHRAX (manufacturer and lot number not reported), INFLUENZA, LIVE, INTRANASAL (manufacturer and lot number not reported) and TYPHIM VI, sanofi pasteur SA (lot number not reported). The subject had an abnormal troponin I on 13 November 2009, a normal echocardiogram on 14 November 2009 and an abnormal ECG on 15 November 2009. The subject was diagnosed with chest pain, unspecified on 13 November 2009. The subject had no significant medical history. No further information was available at the time of the report. The subject's outcome was not reported. Note: there is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received from the investigator on 19 March 2012. Fifteen days post-vaccination, the subject presented to a clinic status post (s/p) four day hospitalization for chest pain (CP) with respiration 3/10, two weeks s/p smallpox vaccine (SPV). Inpatient testing included an ECG that revealed diffuse small ST segment elevations. Cardiac catheterization and enzymes rules out myocardial infarction (MI) and atherosclerotic disease. The subject was asymptomatic and had no prior history of related symptoms. Lungs were clear to auscultation (CTA). Fifteen days post-vaccination, the subject's ECG revealed normal sinus rhythm (NSR), regular rate and rhythm (RRR) and no murmur. "A/P 1) Pericarditis: possibly related to SPV. Resolved." The subject's past medical history (PMH) included testicular cancer, orchidectomy and reflux disease. The subject's family history included cancer on the maternal side. The subject's concomitant medication was "omneprozol." The subject's outcome was recovered. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Headache, Pain
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 451698. A 20-year-old male patient received the following vaccination on 02 March 2012: ACAM2000 (lot number VV04-003-A). On 11 March 2012, the patient experienced headache and body aches. The events required an emergency visit. The patient had no current illnesses and past medical history was not reported. Concomitant medications were not reported. The patient's outcome was recovered. Documents held by sender: None.
Age: 19.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Blister, Injection site rash
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452027. A 19-year-old female patient received the following vaccinations on 01 March 2012: ACAM2000 (VV04-003-A), TYPHIM VI (lot number not reported) and anthrax (manufacturer and lot number not reported). On 17 March 2012, the patient experienced vaccinia inoculation in left upper arm with a rash surrounding the site approximately 10cm with vesicles on right hand and forearm, left forearm and bilateral legs which was possibly due to (d/t) self-inoculation, possibly systemic response. The event required an emergency visit and hospitalization. The patient's other medications included ibuprofen. The patient had no current illnesses and no medical history. The patient's outcome was recovered. Documents held by sender: None.
Age: 19.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Blister, Injection site rash, Post vaccination autoinoculation
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452027. A 19-year-old female patient received the following vaccinations on 01 March 2012: ACAM2000 (VV04-003-A), TYPHIM VI (lot number not reported) and anthrax (manufacturer and lot number not reported). On 17 March 2012, the patient experienced vaccinia inoculation in left upper arm with a rash surrounding the site approximately 10cm with vesicles on right hand and forearm, left forearm and bilateral legs which was possibly due to (d/t) self-inoculation, possibly systemic response. The event required an emergency visit and hospitalization. The patient's other medications included ibuprofen. The patient had no current illnesses and no medical history. The patient's outcome was recovered. Documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Herpes simplex, Polymerase chain reaction, Post vaccination autoinoculation, Skin lesion, Varicella virus test negative
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452133. A 19-year-old male patient received the following vaccinations on 01 March 2012: ACAM2000 (lot number VV04-003-A), TYPHIM VI (lot number B1026) and BIOTHRAX (lot number FAV305). On 02 March 2012, the patient had four lesions consistent with inadvertent inoculation developed over the next few days after vaccination. The patient had three on shoulder/back and one on the left chest. On day eleven he developed upper lip lesion which proved to be herpes simplex virus (HSV) 1 on polymerase chain reaction (PCR) testing. The face lesion was HSV PCR positive and varicella virus (VZV) PCR negative and the distant shoulder lesion was HSV and VZV negative. The results were discussed with the state lab who felt vaccinia PCR was not indicated for face lesion considering positive HSV and appearance consistent with HSV. The event required an emergency visit. The patient took no concomitant medications, had no current illnesses and no past medical history. The patient's outcome was recovered. Documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Oral herpes, Polymerase chain reaction, Post vaccination autoinoculation, Simplex virus test positive, Skin lesion
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452133. A 19-year-old male patient received the following vaccinations on 01 March 2012: ACAM2000 (lot number VV04-003-A), TYPHIM VI (lot number B1026) and BIOTHRAX (lot number FAV305). On 02 March 2012, the patient had four lesions consistent with inadvertent inoculation developed over the next few days after vaccination. The patient had three on shoulder/back and one on the left chest. On day eleven he developed upper lip lesion which proved to be herpes simplex virus (HSV) 1 on polymerase chain reaction (PCR) testing. The face lesion was HSV PCR positive and varicella virus (VZV) PCR negative and the distant shoulder lesion was HSV and VZV negative. The results were discussed with the state lab who felt vaccinia PCR was not indicated for face lesion considering positive HSV and appearance consistent with HSV. The event required an emergency visit. The patient took no concomitant medications, had no current illnesses and no past medical history. The patient's outcome was recovered. Documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Varicella virus test negative
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452133. A 19-year-old male patient received the following vaccinations on 01 March 2012: ACAM2000 (lot number VV04-003-A), TYPHIM VI (lot number B1026) and BIOTHRAX (lot number FAV305). On 02 March 2012, the patient had four lesions consistent with inadvertent inoculation developed over the next few days after vaccination. The patient had three on shoulder/back and one on the left chest. On day eleven he developed upper lip lesion which proved to be herpes simplex virus (HSV) 1 on polymerase chain reaction (PCR) testing. The face lesion was HSV PCR positive and varicella virus (VZV) PCR negative and the distant shoulder lesion was HSV and VZV negative. The results were discussed with the state lab who felt vaccinia PCR was not indicated for face lesion considering positive HSV and appearance consistent with HSV. The event required an emergency visit. The patient took no concomitant medications, had no current illnesses and no past medical history. The patient's outcome was recovered. Documents held by sender: None.
Age: 23.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Dysuria, Orthopoxvirus test positive, Pain, Paraesthesia, Pruritus
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452153. A 23-year-old female patient was exposed to someone who was vaccinated with ACAM2000 (lot number not reported) on 22 February 2012. The patient had intimate contact with the primary vaccine on 26 February 2012, 29 February 2012, 03 March 2012 and 08 March 2012. During at least one of these encounters the vaccination site dressing came dislodged/off. On 11 March 2012, the patient developed fever, body aches and vaginal pruritis. On 12 March 2012, the patient developed itchy lesions on her thigh and vulva. The patient scratched all of the lesions and irritated the areas. Additionally she applied TEMOVATE cream to her vaginal area. The patient developed a lesion on her back on 13 March 2012. The lesion to the thigh and vulva tested positive for orthopox  virus (per LPN) on 15 March 2012. The patient used tampons to manage menses from 12 March 2012 to 15 March 2012. The patient was treated with VIG on 17 March 2012. The patient also had the symptoms of dysuria and disturbance of skin sensation. The events required an emergency visit. The patient had a history of eczema, seasonal allergies and was allergic to cats and some soaps. The patient's outcome was unknown. Documents held by sender: None.
Age: 23.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Pyrexia, Skin irritation, Skin lesion, Vulval disorder, Vulvovaginal pruritus
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452153. A 23-year-old female patient was exposed to someone who was vaccinated with ACAM2000 (lot number not reported) on 22 February 2012. The patient had intimate contact with the primary vaccine on 26 February 2012, 29 February 2012, 03 March 2012 and 08 March 2012. During at least one of these encounters the vaccination site dressing came dislodged/off. On 11 March 2012, the patient developed fever, body aches and vaginal pruritis. On 12 March 2012, the patient developed itchy lesions on her thigh and vulva. The patient scratched all of the lesions and irritated the areas. Additionally she applied TEMOVATE cream to her vaginal area. The patient developed a lesion on her back on 13 March 2012. The lesion to the thigh and vulva tested positive for orthopox  virus (per LPN) on 15 March 2012. The patient used tampons to manage menses from 12 March 2012 to 15 March 2012. The patient was treated with VIG on 17 March 2012. The patient also had the symptoms of dysuria and disturbance of skin sensation. The events required an emergency visit. The patient had a history of eczema, seasonal allergies and was allergic to cats and some soaps. The patient's outcome was unknown. Documents held by sender: None.
Age: 23.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Dysuria, Immunoglobulin therapy, Orthopoxvirus test positive, Pain, Paraesthesia
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452153. A 23-year-old female patient was exposed to someone who was vaccinated with ACAM2000 (lot number not reported) on 22 February 2012. The patient had intimate contact with the primary vaccine on 26 February 2012, 29 February 2012, 03 March 2012 and 08 March 2012. During at least one of these encounters the vaccination site dressing came dislodged/off. On 11 March 2012, the patient developed fever, body aches and vaginal pruritis. On 12 March 2012, the patient developed itchy lesions on her thigh and vulva. The patient scratched all of the lesions and irritated the areas. Additionally she applied TEMOVATE cream to her vaginal area. The patient developed a lesion on her back on 13 March 2012. The lesion to the thigh and vulva tested positive for orthopox  virus (per LPN) on 15 March 2012. The patient used tampons to manage menses from 12 March 2012 to 15 March 2012. The patient was treated with VIG on 17 March 2012. The patient also had the symptoms of dysuria and disturbance of skin sensation. The events required an emergency visit. The patient had a history of eczema, seasonal allergies and was allergic to cats and some soaps. The patient's outcome was unknown. Documents held by sender: None.
Age: 23.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Pruritus, Pyrexia, Secondary transmission, Skin irritation, Skin lesion
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452153. A 23-year-old female patient was exposed to someone who was vaccinated with ACAM2000 (lot number not reported) on 22 February 2012. The patient had intimate contact with the primary vaccine on 26 February 2012, 29 February 2012, 03 March 2012 and 08 March 2012. During at least one of these encounters the vaccination site dressing came dislodged/off. On 11 March 2012, the patient developed fever, body aches and vaginal pruritis. On 12 March 2012, the patient developed itchy lesions on her thigh and vulva. The patient scratched all of the lesions and irritated the areas. Additionally she applied TEMOVATE cream to her vaginal area. The patient developed a lesion on her back on 13 March 2012. The lesion to the thigh and vulva tested positive for orthopox  virus (per LPN) on 15 March 2012. The patient used tampons to manage menses from 12 March 2012 to 15 March 2012. The patient was treated with VIG on 17 March 2012. The patient also had the symptoms of dysuria and disturbance of skin sensation. The events required an emergency visit. The patient had a history of eczema, seasonal allergies and was allergic to cats and some soaps. The patient's outcome was unknown. Documents held by sender: None.
Age: 23.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Vulval disorder, Vulvovaginal pruritus
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452153. A 23-year-old female patient was exposed to someone who was vaccinated with ACAM2000 (lot number not reported) on 22 February 2012. The patient had intimate contact with the primary vaccine on 26 February 2012, 29 February 2012, 03 March 2012 and 08 March 2012. During at least one of these encounters the vaccination site dressing came dislodged/off. On 11 March 2012, the patient developed fever, body aches and vaginal pruritis. On 12 March 2012, the patient developed itchy lesions on her thigh and vulva. The patient scratched all of the lesions and irritated the areas. Additionally she applied TEMOVATE cream to her vaginal area. The patient developed a lesion on her back on 13 March 2012. The lesion to the thigh and vulva tested positive for orthopox  virus (per LPN) on 15 March 2012. The patient used tampons to manage menses from 12 March 2012 to 15 March 2012. The patient was treated with VIG on 17 March 2012. The patient also had the symptoms of dysuria and disturbance of skin sensation. The events required an emergency visit. The patient had a history of eczema, seasonal allergies and was allergic to cats and some soaps. The patient's outcome was unknown. Documents held by sender: None.
Age: 42.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Drug administration error, Lymphadenopathy
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452210. A 42-year-old male patient received the following vaccinations on 02 March 2012: ACAM2000 (lot number VV04-003-A), TYPHIM VI (lot number E0576) and BIOTHRAX (lot number FAV305). During vaccination, the administrator seemed rushed, pushing pre-screening paperwork in order to begin vaccine process. The administrator did not clean the area with alcohol prior to administering typhoid, anthrax booster and smallpox. The patient was briefed that smallpox vaccine would consist of 15 small pricks, but several others were administered. Within several days, the patient had swollen glands under smallpox armpit with achy feeling and streaking. The symptoms progressively worsened over time. The patient saw medical personnel for streaking and was sent to the emergency room (ER). The patient was treated with vancomycin 2 grams via IV with prescription for clindamycin 150mg 2 capsules every 6 hours (total of #56 capsules). The patient was to maintain follow-up with medical doctors every 2-3 days in order to monitor site and treatment plan. The patient's concomitant medications included CLARITIN. The patient had no current illnesses and a history of seasonal allergies. The patient's outcome was recovered. Documents held by sender: None.
Age: 42.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Axillary pain, Drug administration error, Erythema, Lymphadenopathy
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452210. A 42-year-old male patient received the following vaccinations on 02 March 2012: ACAM2000 (lot number VV04-003-A), TYPHIM VI (lot number E0576) and BIOTHRAX (lot number FAV305). During vaccination, the administrator seemed rushed, pushing pre-screening paperwork in order to begin vaccine process. The administrator did not clean the area with alcohol prior to administering typhoid, anthrax booster and smallpox. The patient was briefed that smallpox vaccine would consist of 15 small pricks, but several others were administered. Within several days, the patient had swollen glands under smallpox armpit with achy feeling and streaking. The symptoms progressively worsened over time. The patient saw medical personnel for streaking and was sent to the emergency room (ER). The patient was treated with vancomycin 2 grams via IV with prescription for clindamycin 150mg 2 capsules every 6 hours (total of #56 capsules). The patient was to maintain follow-up with medical doctors every 2-3 days in order to monitor site and treatment plan. The patient's concomitant medications included CLARITIN. The patient had no current illnesses and a history of seasonal allergies. The patient's outcome was recovered. Documents held by sender: None.
Age: 28.0
Sex: M
Vaccine: ANTH, SMALL, TDAP, TYP, ANTH, SMALL, TDAP, TYP, ANTH, SMALL, TDAP, TYP
Symptoms: Discomfort, Pruritus, Rash erythematous
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452286. A 28-year-old male patient received the following vaccinations on 02 March 2012: ACAM2000 (lot number VV04-003-A), ADACEL (lot number C3900AA), TYPHIM VI (lot number G1130) and BIOTHRAX (lot number FAV305). On 15 March 2012, the patient had red bumps on hands and knuckles with few on the member's heels that were itchy and less red under cold water. The onset was approximately two weeks after vaccination. No laboratory testing was performed, only supportive care was given for itching/discomfort. The provider recommended possible immunology referral. The patient still has the bumps. The patient had no current illnesses and no past medical history. The patient took no concomitant medications. The patient's outcome was unknown. Documents held by sender: None.
Age: 28.0
Sex: M
Vaccine: ANTH, SMALL, TDAP, TYP, ANTH, SMALL, TDAP, TYP, ANTH, SMALL, TDAP, TYP
Symptoms: Rash papular, Rash pruritic
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452286. A 28-year-old male patient received the following vaccinations on 02 March 2012: ACAM2000 (lot number VV04-003-A), ADACEL (lot number C3900AA), TYPHIM VI (lot number G1130) and BIOTHRAX (lot number FAV305). On 15 March 2012, the patient had red bumps on hands and knuckles with few on the member's heels that were itchy and less red under cold water. The onset was approximately two weeks after vaccination. No laboratory testing was performed, only supportive care was given for itching/discomfort. The provider recommended possible immunology referral. The patient still has the bumps. The patient had no current illnesses and no past medical history. The patient took no concomitant medications. The patient's outcome was unknown. Documents held by sender: None.
Age: 28.0
Sex: M
Vaccine: ANTH, SMALL, TDAP, TYP, ANTH, SMALL, TDAP, TYP, ANTH, SMALL, TDAP, TYP
Symptoms: Discomfort, Pruritus, Rash, Rash erythematous
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452286. A 28-year-old male patient received the following vaccinations on 02 March 2012: ACAM2000 (lot number VV04-003-A), ADACEL (lot number C3900AA), TYPHIM VI (lot number G1130) and BIOTHRAX (lot number FAV305). On 15 March 2012, the patient had red bumps on hands and knuckles with few on the member's heels that were itchy and less red under cold water. The onset was approximately two weeks after vaccination. No laboratory testing was performed, only supportive care was given for itching/discomfort. The provider recommended possible immunology referral. The patient still has the bumps. The patient had no current illnesses and no past medical history. The patient took no concomitant medications. The patient's outcome was unknown. Documents held by sender: None.
Age: 25.0
Sex: M
Vaccine: ANTH, SMALL, YF, ANTH, SMALL, YF
Symptoms: Activities of daily living impaired, Chest X-ray, Chest discomfort, Dyspnoea, Laboratory test
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452354. A 25-year-old male patient received the following vaccinations on 29 February 2012: ACAM2000 (lot number VV04-003-A), YF VAX (lot number UH278AA) and BIOTHRAX (lot number FAV305). On 09 March 2012, the patient experienced tightness in chest and shortness of breath occasionally through 23 March 2012. The patient came into the clinic on 23 March 2012 and was seen by a doctor. The patient was a pilot so he was restricted from flying duties and from running/speed walking for 30 days. The patient had a chest x-ray and lab tests (details not reported). The events required an emergency visit. The patient had no current illnesses and no past medical history. The patient took no concomitant medications. The patient's outcome was recovered. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Cellulitis, Injection site erythema, Injection site oedema, Injection site pain, Injection site swelling
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452429. A 21-year-old male patient received the following vaccination on 14 March 2012: ACAM2000 (lot number VV04-003-A). On 24 March 2012, the patient experienced pain, swelling, edema, erythema, warm to site and was diagnosed with cellulitis. The patient was treated with SEPTRA DS 10mg oral (po) twice daily (BID) for 10 days. The patient had no current illnesses and no past medical history. The patient's outcome was recovered. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Injection site warmth
Clinical narrative: This case was received on 30 May 2012 via a third party query tool search on the VAERS database, under reference number 452429. A 21-year-old male patient received the following vaccination on 14 March 2012: ACAM2000 (lot number VV04-003-A). On 24 March 2012, the patient experienced pain, swelling, edema, erythema, warm to site and was diagnosed with cellulitis. The patient was treated with SEPTRA DS 10mg oral (po) twice daily (BID) for 10 days. The patient had no current illnesses and no past medical history. The patient's outcome was recovered. Documents held by sender: None.
Age: 19.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Orthopoxvirus test positive, Polymerase chain reaction, Scab, Secondary transmission, Skin lesion
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number VAERS ID# 452970. A 19-year-old female patient experienced secondary transmission and developed facial lesions which were positive for non-variola orthopox after having intimate contact on 09 March 2012 with a primary vaccinee who had received ACAM2000 (lot number not reported) on 02 March 2012. The primary vaccinee's vaccination site was not covered and he had been wearing a short sleeve shirt during intimate contact. On 13 March 2012, the patient noted five facial lesions (left and right cheek and chin) which were originally treated with KEFLEX, and then BACTRIM. The event required an emergency room visit. On 22 March 2012, the lesions tested PCR positive for non-variola orthopox. As of 02 April 2012, the lesions were scabbed. Other medications, current illnesses and history were reported as "none". Outcome was reported as unknown. Documents held by sender: None.
Age: 36.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Arthralgia, Intensive care, Myalgia, Polymerase chain reaction, Rash
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453011. A 36-year-old male patient received the following vaccinations on 21 March 2012: ACAM2000 (lot number VV04003A), BIOTHRAX (lot number FAV296). The patient had no current illnesses, no pre-existing conditions, no birth defects, no medical conditions. Other medications included TYLENOL as needed. Seven days post vaccination/inoculation the patient developed skin rash and arthralgia with muscle ache and was admitted to the ICU (intensive care unit) in the hospital 13 days after SPV (small pox vaccinations), which is estimated to be on 03 April 2012. Laboratory data included swabs of skin rash for vaccinia (viral test, no result) and PCR (polymerase chain reaction) were sent on 03 April 2012. Results were pending at the time of the report. Hospital discharge date not reported. Recovery status was unknown. Documents held by sender: None.
Age: 36.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Viral test
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453011. A 36-year-old male patient received the following vaccinations on 21 March 2012: ACAM2000 (lot number VV04003A), BIOTHRAX (lot number FAV296). The patient had no current illnesses, no pre-existing conditions, no birth defects, no medical conditions. Other medications included TYLENOL as needed. Seven days post vaccination/inoculation the patient developed skin rash and arthralgia with muscle ache and was admitted to the ICU (intensive care unit) in the hospital 13 days after SPV (small pox vaccinations), which is estimated to be on 03 April 2012. Laboratory data included swabs of skin rash for vaccinia (viral test, no result) and PCR (polymerase chain reaction) were sent on 03 April 2012. Results were pending at the time of the report. Hospital discharge date not reported. Recovery status was unknown. Documents held by sender: None.
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Injection site cellulitis, Rash generalised
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453170. A 26-year-old male patient with no reported medical history received the following vaccinations on 25 March 2012: ACAM2000 (lot number VV04003A), typhoid (no brand name and manufacturer unknown, lot number not reported), anthrax (No brand name, lot number not reported). Although the manufacturer was reported as unknown in this case for small pox vaccine, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Eight days post vaccination/inoculation the patient developed cellulitis at the site of vaccination (not specified) and non-specific generalized rash that had begun on the arms and travelled to the thorax and legs sparing the hands and feet. The patient was vaccinated through work and seen in the ER (emergency room) for the rash 2 days later. Recovery status was unknown. Documents held by sender: None.
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Chills, Headache, Rash
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453170. A 26-year-old male patient with no reported medical history received the following vaccinations on 25 March 2012: ACAM2000 (lot number VV04003A), typhoid (no brand name and manufacturer unknown, lot number not reported), anthrax (No brand name, lot number not reported). Although the manufacturer was reported as unknown in this case for small pox vaccine, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Eight days post vaccination/inoculation the patient developed cellulitis at the site of vaccination (not specified) and non-specific generalized rash that had begun on the arms and travelled to the thorax and legs sparing the hands and feet. The patient was vaccinated through work and seen in the ER (emergency room) for the rash 2 days later. Recovery status was unknown. Documents held by sender: None.
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Rash generalised, Vaccination site cellulitis
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453170. A 26-year-old male patient with no reported medical history received the following vaccinations on 25 March 2012: ACAM2000 (lot number VV04003A), typhoid (no brand name and manufacturer unknown, lot number not reported), anthrax (No brand name, lot number not reported). Although the manufacturer was reported as unknown in this case for small pox vaccine, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Eight days post vaccination/inoculation the patient developed cellulitis at the site of vaccination (not specified) and non-specific generalized rash that had begun on the arms and travelled to the thorax and legs sparing the hands and feet. The patient was vaccinated through work and seen in the ER (emergency room) for the rash 2 days later. Recovery status was unknown. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: SMALL, TYP, SMALL, TYP
Symptoms: Echocardiogram abnormal, Electrocardiogram abnormal, Pericardial disease, Pericarditis, Troponin I increased
Clinical narrative: This study case was received from the investigator in a trial on 04 April 2012. A 22-year-old male subject received the following vaccinations on 27 December 2011: an injection of ACAM2000 (lot number not reported) and TYPHIM VI, sanofi pasteur SA (lot number not reported). The subject had no significant medical history. On 09 January 2012, the subject had an abnormal troponin I of 11.05, an abnormal electrocardiogram (ECG) and an abnormal echocardiogram. On 08 January 2012, the subject was diagnosed with unspecified disease of pericardium and on 09 January 2012, the subject was diagnosed with acute pericarditis, unspecified. The outcome was not reported. Additional information will be requested from the investigator. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 13 July 2012 via a third party query tool search on the VAERS database. The VAERS ID reference number for this case was 453477. No additional information was provided. Documents held by sender: None.
Age: 31.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Echocardiogram normal, Electrocardiogram abnormal, Myocardial infarction, Troponin I increased
Clinical narrative: This study case was received from the investigator in a trial on 04 April 2012. A 31-year-old male subject received the following vaccinations: On 06 January 2012: an injection of ACAM2000 (lot number not reported) and on 14 December 2011: an injection of TYPHIM VI, sanofi pasteur, SA, lot number not reported, an injection of ANTHRAX 1 (manufacturer and lot number not reported) and an injection of HEPATITIS B ADULT (manufacturer and lot number not reported). The subject had a history of elevated cholesterol. On 19 January 2012, the subject had an abnormal troponin I of 00.52, an abnormal electrocardiogram (ECG) and a normal echocardiogram. On 24 January 2012, the subject was diagnosed with subendocardial infarction. The outcome was not reported. Additional information will be requested from the investigator. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received 13 July 2012 via a third party query tool search on the VAERS database. The VAERS ID reference number for this case was 453482. No new information was provided. The outcome remained not reported. Documents held by sender: None.
Age: 31.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Echocardiogram normal, Electrocardiogram abnormal, Myocardial infarction, Troponin I, Troponin I increased
Clinical narrative: This study case was received from the investigator in a trial on 04 April 2012. A 31-year-old male subject received the following vaccinations: On 06 January 2012: an injection of ACAM2000 (lot number not reported) and on 14 December 2011: an injection of TYPHIM VI, sanofi pasteur, SA, lot number not reported, an injection of ANTHRAX 1 (manufacturer and lot number not reported) and an injection of HEPATITIS B ADULT (manufacturer and lot number not reported). The subject had a history of elevated cholesterol. On 19 January 2012, the subject had an abnormal troponin I of 00.52, an abnormal electrocardiogram (ECG) and a normal echocardiogram. On 24 January 2012, the subject was diagnosed with subendocardial infarction. The outcome was not reported. Additional information will be requested from the investigator. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received 13 July 2012 via a third party query tool search on the VAERS database. The VAERS ID reference number for this case was 453482. No new information was provided. The outcome remained not reported. Documents held by sender: None.
Age: 48.0
Sex: F
Vaccine: ANTH, FLUN3, HEP, SMALL, TYP, ANTH, FLUN3, HEP, SMALL, TYP
Symptoms: Autonomic nervous system imbalance, Breast cancer, Dyspnoea, Flushing, Mastocytosis
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453686. A 48-year-old female patient with no medical history received the following vaccinations on 09 October 2008: ACAM2000 (lot number VV04003A), TYPHIM VI (lot number A09233), anthrax (No brand name, lot number unknown), FLUMIST (Medimmune, lot number 500549P), ENGERIX B (lot number AHBVB596CA). Although the manufacturer was reported as unknown for small pox vaccine, in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Twenty-three days post vaccinations/inoculation the patient developed shortness of breath while on travel requiring emergency visit. A diagnosis was never made. But now it is thought the patient has the beginnings of dysautonomia, or the beginning of mast cell activation syndrome. In 2009 she developed dysautonomia in the form of postural orthostatic tachycardia syndrome after receiving radiation for breast CA (cancer). She also went on to develop multiple symptoms of mast cell activation including flushing episodes, urticaria and increased number of episodes of SOB (shortness of breath). The patient was treated partially with H1 and H2 blockers and mast cell stabilizer medications. Laboratory data was reported as "none at the time". The patient has not recovered. Documents held by sender: None.
Age: 48.0
Sex: F
Vaccine: ANTH, FLUN3, HEP, SMALL, TYP, ANTH, FLUN3, HEP, SMALL, TYP
Symptoms: Postural orthostatic tachycardia syndrome, Radiotherapy, Urticaria
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453686. A 48-year-old female patient with no medical history received the following vaccinations on 09 October 2008: ACAM2000 (lot number VV04003A), TYPHIM VI (lot number A09233), anthrax (No brand name, lot number unknown), FLUMIST (Medimmune, lot number 500549P), ENGERIX B (lot number AHBVB596CA). Although the manufacturer was reported as unknown for small pox vaccine, in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Twenty-three days post vaccinations/inoculation the patient developed shortness of breath while on travel requiring emergency visit. A diagnosis was never made. But now it is thought the patient has the beginnings of dysautonomia, or the beginning of mast cell activation syndrome. In 2009 she developed dysautonomia in the form of postural orthostatic tachycardia syndrome after receiving radiation for breast CA (cancer). She also went on to develop multiple symptoms of mast cell activation including flushing episodes, urticaria and increased number of episodes of SOB (shortness of breath). The patient was treated partially with H1 and H2 blockers and mast cell stabilizer medications. Laboratory data was reported as "none at the time". The patient has not recovered. Documents held by sender: None.
Age: 48.0
Sex: F
Vaccine: ANTH, FLUN3, HEP, SMALL, TYP, ANTH, FLUN3, HEP, SMALL, TYP
Symptoms: Autonomic nervous system imbalance, Breast cancer female, Dyspnoea, Flushing, Mastocytosis
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453686. A 48-year-old female patient with no medical history received the following vaccinations on 09 October 2008: ACAM2000 (lot number VV04003A), TYPHIM VI (lot number A09233), anthrax (No brand name, lot number unknown), FLUMIST (Medimmune, lot number 500549P), ENGERIX B (lot number AHBVB596CA). Although the manufacturer was reported as unknown for small pox vaccine, in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Twenty-three days post vaccinations/inoculation the patient developed shortness of breath while on travel requiring emergency visit. A diagnosis was never made. But now it is thought the patient has the beginnings of dysautonomia, or the beginning of mast cell activation syndrome. In 2009 she developed dysautonomia in the form of postural orthostatic tachycardia syndrome after receiving radiation for breast CA (cancer). She also went on to develop multiple symptoms of mast cell activation including flushing episodes, urticaria and increased number of episodes of SOB (shortness of breath). The patient was treated partially with H1 and H2 blockers and mast cell stabilizer medications. Laboratory data was reported as "none at the time". The patient has not recovered. Documents held by sender: None.
Age: 48.0
Sex: F
Vaccine: ANTH, FLUN3, HEP, SMALL, TYP, ANTH, FLUN3, HEP, SMALL, TYP
Symptoms: Postural orthostatic tachycardia syndrome, Urticaria
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453686. A 48-year-old female patient with no medical history received the following vaccinations on 09 October 2008: ACAM2000 (lot number VV04003A), TYPHIM VI (lot number A09233), anthrax (No brand name, lot number unknown), FLUMIST (Medimmune, lot number 500549P), ENGERIX B (lot number AHBVB596CA). Although the manufacturer was reported as unknown for small pox vaccine, in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Twenty-three days post vaccinations/inoculation the patient developed shortness of breath while on travel requiring emergency visit. A diagnosis was never made. But now it is thought the patient has the beginnings of dysautonomia, or the beginning of mast cell activation syndrome. In 2009 she developed dysautonomia in the form of postural orthostatic tachycardia syndrome after receiving radiation for breast CA (cancer). She also went on to develop multiple symptoms of mast cell activation including flushing episodes, urticaria and increased number of episodes of SOB (shortness of breath). The patient was treated partially with H1 and H2 blockers and mast cell stabilizer medications. Laboratory data was reported as "none at the time". The patient has not recovered. Documents held by sender: None.
Age: 18.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Hypoaesthesia, Injected limb mobility decreased, Robust take following exposure to vaccinia virus
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453783. An 18-year-old male patient received the following vaccinations on 02 April 2012: ACAM2000 (lot number VV04003A), TYPHIM VI (lot number B1026), and BIOTHRAX (lot number FAV303). Seven days post vaccination/inoculation the patient reported having a difficult time moving his right upper extremity and stated had numbness down the right arm. It was noted that he had a major reaction "Take" and is fully immunized. Laboratory data: the patient was sent to his PCM for evaluation. Medical history, current illnesses, other medications were reported as "None". The recovery status was unknown. Documents held by sender: None.
Age: 32.0
Sex: F
Vaccine: SMALL, SMALL, SMALL
Symptoms: Catheterisation cardiac, Chest pain
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453892. A 32-year-old female patient received the following vaccination on 05/Apr/2012: ACAM2000 (lot number VV04003A). The patient had medical history of latex allergy and adjustment disorder. Other medications were reported as none. Twelve days post inoculation the patient complained of chest pain and was sent to the ER (emergency room) and hospitalized. Per the patient, heart catheterization was performed and she was admitted to telemetry. Laboratory data was performed at the hospital (results not provided). Recovery status was unknown. Documents held by sender: None.
Age: 32.0
Sex: F
Vaccine: SMALL, SMALL, SMALL
Symptoms: Abdominal discomfort, Angina pectoris, Axillary pain, Back pain, Balance disorder
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453892. A 32-year-old female patient received the following vaccination on 05/Apr/2012: ACAM2000 (lot number VV04003A). The patient had medical history of latex allergy and adjustment disorder. Other medications were reported as none. Twelve days post inoculation the patient complained of chest pain and was sent to the ER (emergency room) and hospitalized. Per the patient, heart catheterization was performed and she was admitted to telemetry. Laboratory data was performed at the hospital (results not provided). Recovery status was unknown. Documents held by sender: None.
Age: 32.0
Sex: F
Vaccine: SMALL, SMALL, SMALL
Symptoms: Catheterisation cardiac normal, Chest discomfort, Chest pain, Dizziness, Dyspnoea
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453892. A 32-year-old female patient received the following vaccination on 05/Apr/2012: ACAM2000 (lot number VV04003A). The patient had medical history of latex allergy and adjustment disorder. Other medications were reported as none. Twelve days post inoculation the patient complained of chest pain and was sent to the ER (emergency room) and hospitalized. Per the patient, heart catheterization was performed and she was admitted to telemetry. Laboratory data was performed at the hospital (results not provided). Recovery status was unknown. Documents held by sender: None.
Age: 32.0
Sex: F
Vaccine: SMALL, SMALL, SMALL
Symptoms: Echocardiogram normal, Fatigue, Nausea, Oropharyngeal pain, Pain in jaw
Clinical narrative: This case was received on 13 July 2012 via a third party query tool search on the VAERS database, under reference number 453892. A 32-year-old female patient received the following vaccination on 05/Apr/2012: ACAM2000 (lot number VV04003A). The patient had medical history of latex allergy and adjustment disorder. Other medications were reported as none. Twelve days post inoculation the patient complained of chest pain and was sent to the ER (emergency room) and hospitalized. Per the patient, heart catheterization was performed and she was admitted to telemetry. Laboratory data was performed at the hospital (results not provided). Recovery status was unknown. Documents held by sender: None.